Current problems in burn immunology.

[1]  Koichi Yuki,et al.  Volatile Anesthetic Attenuates Phagocyte Function and Worsens Bacterial Loads in Wounds. , 2019, The Journal of surgical research.

[2]  V. Afreixo,et al.  Evaluation of Procalcitonin Accuracy for the Distinction Between Gram-Negative and Gram-Positive Bacterial Sepsis in Burn Patients. , 2018, Journal of burn care & research : official publication of the American Burn Association.

[3]  A. Hapfelmeier,et al.  A Randomized Controlled Trial: Regenerative Effects, Efficacy and Safety of Erythropoietin in Burn and Scalding Injuries , 2018, Front. Pharmacol..

[4]  F. Hildebrand,et al.  Using IL-6 concentrations in the first 24 h following trauma to predict immunological complications and mortality in trauma patients: a meta-analysis , 2018, European Journal of Trauma and Emergency Surgery.

[5]  D. Amtmann,et al.  Reduced Postburn Hypertrophic Scarring and Improved Physical Recovery With Yearlong Administration of Oxandrolone and Propranolol , 2018, Annals of surgery.

[6]  Yan Huang,et al.  Do low-dose corticosteroids improve survival or shock reversal from septic shock in adults? Meta-analysis with trial sequential analysis , 2018, The Journal of international medical research.

[7]  E. Sherwood,et al.  Frontline Science: Anti‐PD‐L1 protects against infection with common bacterial pathogens after burn injury , 2018, Journal of leukocyte biology.

[8]  F. Chang,et al.  Procalcitonin as a diagnostic biomarker for septic shock and bloodstream infection in burn patients from the Formosa Fun Coast dust explosion. , 2017, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[9]  J. Cancelas,et al.  Thermal injury of the skin induces G-CSF-dependent attenuation of EPO-mediated STAT signaling and erythroid differentiation arrest in mice. , 2017, Experimental hematology.

[10]  D. Herndon,et al.  Treatment of infection in burn patients , 2017 .

[11]  Makiko Kobayashi,et al.  Host Defense Antibacterial Effector Cells Influenced by Massive Burns , 2017 .

[12]  V. Afreixo,et al.  Procalcitonin for the early diagnosis of sepsis in burn patients: A retrospective study. , 2017, Burns : journal of the International Society for Burn Injuries.

[13]  K. Leung,et al.  Toll-Like Receptor Signaling in Burn Wound Healing and Scarring. , 2017, Advances in wound care.

[14]  H. Karimi,et al.  Correlation of occurrence of infection in burn patients. , 2017, Annals of burns and fire disasters.

[15]  I. Whitaker,et al.  Measuring coagulation in burns: an evidence-based systematic review , 2017, Scars, burns & healing.

[16]  J. Lorente,et al.  Digestive decontamination in burn patients: A systematic review of randomized clinical trials and observational studies. , 2017, Burns : journal of the International Society for Burn Injuries.

[17]  D. Herndon,et al.  Herpesviradae infections in severely burned children. , 2017, Burns : journal of the International Society for Burn Injuries.

[18]  J. Christie,et al.  Antiseptics for burns. , 2017, The Cochrane database of systematic reviews.

[19]  D. Herndon,et al.  The P50 Research Center in Perioperative Sciences: How the investment by the National Institute of General Medical Sciences in team science has reduced postburn mortality , 2017, The journal of trauma and acute care surgery.

[20]  G. Ramos,et al.  Systemic antimicrobial prophylaxis in burn patients: systematic review. , 2017, The Journal of hospital infection.

[21]  Shan Liu,et al.  Recombinant human granulocyte macrophage colony stimulating factor in deep second-degree burn wound healing , 2017, Medicine.

[22]  S. Wolf,et al.  Nutrition and metabolism in burn patients , 2017, Burns & Trauma.

[23]  L. Moldawer,et al.  Persistent Inflammation, Immunosuppression and Catabolism Syndrome. , 2017, Critical care clinics.

[24]  Meenakshi Rani,et al.  Damage-associated molecular patterns (DAMPs) released after burn are associated with inflammation and monocyte activation. , 2017, Burns : journal of the International Society for Burn Injuries.

[25]  J. Bohannon,et al.  Fms-like tyrosine kinase-3 ligand increases resistance to burn wound infection through effects on plasmacytoid dendritic cells , 2017, BMC Immunology.

[26]  R. Martindale,et al.  Nutrition Support for Persistent Inflammation, Immunosuppression, and Catabolism Syndrome. , 2017, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[27]  D. Herndon,et al.  Human herpes viruses in burn patients: A systematic review. , 2017, Burns : journal of the International Society for Burn Injuries.

[28]  V. Afreixo,et al.  The Use of Procalcitonin (PCT) for Diagnosis of Sepsis in Burn Patients: A Meta-Analysis , 2016, PloS one.

[29]  E. Tredget,et al.  Serum Decorin, Interleukin-1&bgr;, and Transforming Growth Factor-&bgr; Predict Hypertrophic Scarring Postburn , 2016, Journal of burn care & research : official publication of the American Burn Association.

[30]  R. Tompkins,et al.  The Metabolic Stress Response to Burn Trauma: Current Understanding and Therapies , 2016, The Lancet.

[31]  Q. Zhang,et al.  [Phase Ⅳ clinical trial for external use of recombinant human granulocyte-macrophage colony-stimulating factor gel in treating deep partial-thickness burn wounds]. , 2016, Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns.

[32]  Seung‐Jung Park,et al.  Impact of exercise-based cardiac rehabilitation on long-term clinical outcomes in patients with left main coronary artery stenosis , 2016, European journal of preventive cardiology.

[33]  M. Jeschke,et al.  Impaired Immune Response in Elderly Burn Patients: New Insights Into the Immune-senescence Phenotype , 2016, Annals of surgery.

[34]  Xiao-ming Meng,et al.  TGF-β: the master regulator of fibrosis , 2016, Nature Reviews Nephrology.

[35]  J. Vincent,et al.  The Clinical Challenge of Sepsis Identification and Monitoring , 2016, PLoS medicine.

[36]  L. Koenderman,et al.  The role of neutrophils in immune dysfunction during severe inflammation , 2016, Critical Care.

[37]  D. Herndon,et al.  Infection in Burns. , 2016, Surgical infections.

[38]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[39]  J. Schachter,et al.  Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns , 2015, Oncotarget.

[40]  A. Rodríguez-Rodríguez,et al.  The utility of C-reactive protein and procalcitonin for sepsis diagnosis in critically burned patients: A preliminary study , 2015 .

[41]  H. Yasunaga,et al.  Prophylactic Antibiotics May Improve Outcome in Patients With Severe Burns Requiring Mechanical Ventilation: Propensity Score Analysis of a Japanese Nationwide Database , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  P. Gøtzsche,et al.  Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis. , 2015, The Cochrane database of systematic reviews.

[43]  F. Gao,et al.  Selective decontamination of the digestive tract ameliorates severe burn-induced insulin resistance in rats. , 2015, Burns : journal of the International Society for Burn Injuries.

[44]  Chen Minghua,et al.  Study of the use of recombinant human granulocyte-macrophage colony-stimulating factor hydrogel externally to treat residual wounds of extensive deep partial-thickness burn. , 2015, Burns : journal of the International Society for Burn Injuries.

[45]  F. Stang,et al.  Epidemiology of pneumonia in a burn care unit: the influence of inhalation trauma on pneumonia and of pneumonia on burn mortality. , 2015, Annals of burns and fire disasters.

[46]  A. Mouithys-Mickalad,et al.  Effects of isoflurane and sevoflurane on the neutrophil myeloperoxidase system of horses. , 2015, Veterinary immunology and immunopathology.

[47]  R. Martindale,et al.  Evolving paradigms in the nutritional support of critically ill surgical patients. , 2015, Current problems in surgery.

[48]  J. Chai,et al.  Safety of recombinant human granulocyte-macrophage colony-stimulating factor in healing pediatric severe burns. , 2015, Genetics and molecular research : GMR.

[49]  D. Herndon,et al.  Predictive Value of IL-8 for Sepsis and Severe Infections After Burn Injury: A Clinical Study , 2015, Shock.

[50]  M. Poeze,et al.  Arginine and Citrulline and the Immune Response in Sepsis , 2015, Nutrients.

[51]  W. Land.  The Role of Damage-Associated Molecular Patterns in Human Diseases: Part I - Promoting inflammation and immunity. , 2015, Sultan Qaboos University medical journal.

[52]  F. Gottrand,et al.  Impact of fish oils on the outcomes of a mouse model of acute Pseudomonas aeruginosa pulmonary infection. , 2015, The British journal of nutrition.

[53]  T. Rimmele,et al.  Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial , 2015, Critical Care.

[54]  S. Gerber,et al.  Interleukin-12 Preserves the Cutaneous Physical and Immunological Barrier after Radiation Exposure , 2015, Radiation research.

[55]  M. V. van Zelm,et al.  The activation of the adaptive immune system: cross-talk between antigen-presenting cells, T cells and B cells. , 2014, Immunology letters.

[56]  Taku Kambayashi,et al.  Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell? , 2014, Nature Reviews Immunology.

[57]  R. Mariani-Costantini,et al.  Palladium Nanoparticles Induce Disturbances in Cell Cycle Entry and Progression of Peripheral Blood Mononuclear Cells: Paramount Role of Ions , 2014, Journal of immunology research.

[58]  B. Pence,et al.  Exercise training modifies ghrelin and adiponectin concentrations and is related to inflammation in older adults. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[59]  A. Gacouin,et al.  Short-Term Decline in All-Cause Acquired Infections With the Routine Use of a Decontamination Regimen Combining Topical Polymyxin, Tobramycin, and Amphotericin B With Mupirocin and Chlorhexidine in the ICU: A Single-Center Experience* , 2014, Critical care medicine.

[60]  W. Langridge,et al.  The Role of Dendritic Cells in Tissue-Specific Autoimmunity , 2014, Journal of immunology research.

[61]  D. Herndon,et al.  Survivors Versus Nonsurvivors Postburn: Differences in Inflammatory and Hypermetabolic Trajectories , 2014, Annals of surgery.

[62]  N. Gibran,et al.  Micronutrients After Burn Injury: A Review , 2014, Journal of burn care & research : official publication of the American Burn Association.

[63]  M. Fleshner,et al.  Adrenergic and glucocorticoid modulation of the sterile inflammatory response , 2014, Brain, Behavior, and Immunity.

[64]  R. Sesti-Costa,et al.  In vitro activation of mouse neutrophils by recombinant human interferon-gamma: increased phagocytosis and release of reactive oxygen species and pro-inflammatory cytokines. , 2014, International immunopharmacology.

[65]  Y. Vodovotz,et al.  The Central Role of Arginine Catabolism in T-Cell Dysfunction and Increased Susceptibility to Infection After Physical Injury , 2014, Annals of surgery.

[66]  Y. Aboelatta,et al.  Selective digestive decontamination (SDD) as a tool in the management of bacterial translocation following major burns. , 2013, Annals of burns and fire disasters.

[67]  R. Gallo,et al.  Functions of the skin microbiota in health and disease. , 2013, Seminars in immunology.

[68]  A. Omar,et al.  Early detection of pneumonia as a risk factor for mortality in burn patients in Menoufiya University Hospitals, Egypt. , 2013, Annals of burns and fire disasters.

[69]  Ching-mei Hsu,et al.  Blocking TNF-α enhances Pseudomonas aeruginosa-induced mortality in burn mice through induction of IL-1β. , 2013, Cytokine.

[70]  L. Barajas-Nava,et al.  Antibiotic prophylaxis for preventing burn wound infection. , 2013, The Cochrane database of systematic reviews.

[71]  Jeong Eun Choi,et al.  Blood Stream Infections in Patients in the Burn Intensive Care Unit , 2013, Infection & chemotherapy.

[72]  M. Kinoshita,et al.  Immunoenhancing therapy with interleukin‐18 against bacterial infection in immunocompromised hosts after severe surgical stress , 2013, Journal of leukocyte biology.

[73]  M. Shimaoka,et al.  Isoflurane inhibits neutrophil recruitment in the cutaneous Arthus reaction model , 2013, Journal of Anesthesia.

[74]  M. Choudhry,et al.  INTERLEUKIN-22 MODULATES GUT EPITHELIAL AND IMMUNE BARRIER FUNCTIONS FOLLOWING ACUTE ALCOHOL EXPOSURE AND BURN INJURY , 2013, Shock.

[75]  R. Gamelli,et al.  Dendritic Cell Depletion in Burn Patients Is Regulated by MafB Expression , 2012, Journal of burn care & research : official publication of the American Burn Association.

[76]  Christian Hidalgo‐González,et al.  Post-burn hypertrophic scars are characterized by high levels of IL-1β mRNA and protein and TNF-α type I receptors. , 2012, Burns : journal of the International Society for Burn Injuries.

[77]  J. Paratz,et al.  Intensive exercise after thermal injury improves physical, functional, and psychological outcomes , 2012, The journal of trauma and acute care surgery.

[78]  D. Herndon,et al.  The pathophysiology of inhalation injury , 2012 .

[79]  D. Herndon,et al.  Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy. , 2012, Journal of the American College of Surgeons.

[80]  K. Sonoda,et al.  IL‐27 inhibits pathophysiological intraocular neovascularization due to laser burn , 2012, Journal of leukocyte biology.

[81]  M. Baun,et al.  Comparison of Mortality Associated With Sepsis in the Burn, Trauma, and General Intensive Care Unit Patient: A Systematic Review of the Literature , 2012, Shock.

[82]  John D. Storey,et al.  A genomic storm in critically injured humans , 2011, The Journal of experimental medicine.

[83]  Ravi Shankar,et al.  Burn injury dampens erythroid cell production through reprioritizing bone marrow hematopoietic response. , 2011, The Journal of trauma.

[84]  M. Nakashima,et al.  Augmented bacterial elimination by Kupffer cells after IL-18 pretreatment via IFN-γ produced from NK cells in burn-injured mice. , 2011, Burns : journal of the International Society for Burn Injuries.

[85]  I. Laher,et al.  Antioxidant and Anti-Inflammatory Effects of Exercise in Diabetic Patients , 2011, Experimental diabetes research.

[86]  Ronald G. Tompkins,et al.  Dissecting Inflammatory Complications in Critically Injured Patients by Within-Patient Gene Expression Changes: A Longitudinal Clinical Genomics Study , 2011, PLoS medicine.

[87]  Stacie L Buck,et al.  A Comprehensive Review on Marjolin's Ulcers: Diagnosis and Treatment. , 2011, The journal of the American College of Certified Wound Specialists.

[88]  B. Phillips,et al.  Red blood cell transfusion following burn. , 2011, Burns : journal of the International Society for Burn Injuries.

[89]  D. Herndon,et al.  Long-Term Persistance of the Pathophysiologic Response to Severe Burn Injury , 2011, PloS one.

[90]  D. Herndon,et al.  What, how, and how much should patients with burns be fed? , 2011, The Surgical clinics of North America.

[91]  K. Chapman,et al.  The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights , 2011, Molecular and Cellular Endocrinology.

[92]  D. Heyland,et al.  Perioperative use of arginine-supplemented diets: a systematic review of the evidence. , 2011, Journal of the American College of Surgeons.

[93]  J. Lederer,et al.  Regulatory T cells suppress antigen‐driven CD4 T cell reactivity following injury , 2011, Journal of leukocyte biology.

[94]  M. Bohnert,et al.  Putative role of TNF-α, interleukin-8 and ICAM-1 as indicators of an early inflammatory reaction after burn: a morphological and immunohistochemical study of lung tissue of fire victims , 2010, Journal of Clinical Pathology.

[95]  E. Sherwood,et al.  Dendritic Cell Modification of Neutrophil Responses to Infection after Burn Injury , 2010, The Journal of Immunology.

[96]  Katherine Hetz,et al.  Outcomes with the Use of Recombinant Human Erythropoietin in Critically Ill Burn Patients , 2010, The American surgeon.

[97]  Mehmet Toner,et al.  Burn Injury Reduces Neutrophil Directional Migration Speed in Microfluidic Devices , 2010, PloS one.

[98]  G. Lippi,et al.  Disseminated intravascular coagulation in burn injury. , 2010, Seminars in thrombosis and hemostasis.

[99]  P. Persad,et al.  Explosive nasofacial cryptococosis. , 2010, Dermatology Online Journal.

[100]  D. Chinkes,et al.  The leading causes of death after burn injury in a single pediatric burn center , 2009, Critical care.

[101]  A. Corthay,et al.  How do Regulatory T Cells Work? , 2009, Scandinavian journal of immunology.

[102]  B. Atiyeh,et al.  Optimizing burn treatment in developing low- and middle-income countries with limited health care resources (part 1). , 2009, Annals of burns and fire disasters.

[103]  Chunmao Han,et al.  A multicenter clinical trial of recombinant human GM‐CSF hydrogel for the treatment of deep second‐degree burns , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[104]  B. Palmier,et al.  A case of atypical and fatal herpes simplex encephalitis in a severe burn patient. , 2009, Burns : journal of the International Society for Burn Injuries.

[105]  E. Moore,et al.  The evolving rationale for early enteral nutrition based on paradigms of multiple organ failure: a personal journey. , 2009, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[106]  S. McClave,et al.  Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). , 2009, JPEN. Journal of parenteral and enteral nutrition.

[107]  J. Schroeder,et al.  Disseminated Varicella infection in an adult burn victim--a transfused disease? , 2009, Burns : journal of the International Society for Burn Injuries.

[108]  L. D'Amelio,et al.  Concentrations of cytokines IL-6 and IL-10 in plasma of burn patients: their relationship to sepsis and outcome. , 2008, Annals of burns and fire disasters.

[109]  B. Casserly,et al.  The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. , 2008, Clinics in chest medicine.

[110]  A. Singer,et al.  Current management of acute cutaneous wounds. , 2008, The New England journal of medicine.

[111]  P. Marik,et al.  Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature* , 2008, Critical care medicine.

[112]  Imad F. Btaiche,et al.  Oxandrolone in Pediatric Patients with Severe Thermal Burn Injury , 2008, The Annals of pharmacotherapy.

[113]  D. Herndon,et al.  Are serum cytokines early predictors for the outcome of burn patients with inhalation injuries who do not survive? , 2008, Critical care.

[114]  D. Sojka,et al.  Mechanisms of regulatory T‐cell suppression – a diverse arsenal for a moving target , 2008, Immunology.

[115]  P. Sacerdote.  Opioid-induced immunosuppression , 2008, Current opinion in supportive and palliative care.

[116]  M. Parihar,et al.  Oxidative stress and anti-oxidative mobilization in burn injury. , 2008, Burns : journal of the International Society for Burn Injuries.

[117]  A. Accardo-Palumbo,et al.  Decrease of circulating dendritic cells in burn patients. , 2007, Annals of burns and fire disasters.

[118]  P. Scott,et al.  Improvement in postburn hypertrophic scar after treatment with IFN-alpha2b is associated with decreased fibrocytes. , 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[119]  D. Herndon,et al.  Effects of cessation of a structured and supervised exercise conditioning program on lean mass and muscle strength in severely burned children. , 2007, Archives of physical medicine and rehabilitation.

[120]  Michael B. Brenner,et al.  CD1 antigen presentation: how it works , 2007, Nature Reviews Immunology.

[121]  S. Sakaguchi,et al.  Regulatory T cells – a brief history and perspective , 2007, European journal of immunology.

[122]  R. Gamelli,et al.  American Burn Association Consensus Conference to Define Sepsis and Infection in Burns , 2007, Journal of burn care & research : official publication of the American Burn Association.

[123]  A. Ayala,et al.  Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock , 2007, Critical care medicine.

[124]  Hema S Bashyam,et al.  Th1/Th2 cross-regulation and the discovery of IL-10 , 2007, The Journal of experimental medicine.

[125]  N. Shinomiya,et al.  Restoration of Natural IgM Production from Liver B Cells by Exogenous IL-18 Improves the Survival of Burn-Injured Mice Infected with Pseudomonas aeruginosa1 , 2006, The Journal of Immunology.

[126]  M. Berger.  Antioxidant micronutrients in major trauma and burns: evidence and practice. , 2006, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[127]  X. Guan,et al.  [Effect of continuous veno-venous hemofiltration on the plasma level of cytokines in patients with multiple organ dysfunction syndrome]. , 2006, Zhonghua wai ke za zhi [Chinese journal of surgery].

[128]  R. Gamelli,et al.  Effect of blood transfusion on outcome after major burn injury: A multicenter study* , 2006, Critical care medicine.

[129]  D. Herndon,et al.  CYTOKINE EXPRESSION PROFILE OVER TIME IN SEVERELY BURNED PEDIATRIC PATIENTS , 2006, Shock.

[130]  I. Sheen,et al.  A Strong Association Between Down-Regulation of HLA-DR Expression and the Late Mortality in Patients with Severe Acute Pancreatitis , 2006, The American Journal of Gastroenterology.

[131]  D. Church,et al.  Burn Wound Infections , 2006, Clinical Microbiology Reviews.

[132]  C. Coopersmith,et al.  The systemic inflammatory response syndrome. , 2006, Microbes and infection.

[133]  Colin Song,et al.  Meta-analysis of early excision of burns. , 2006, Burns : journal of the International Society for Burn Injuries.

[134]  I. Chaudry,et al.  Opiate analgesics contribute to the development of post-injury immunosuppression. , 2005, The Journal of surgical research.

[135]  K. Eckardt,et al.  Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock* , 2005, Critical care medicine.

[136]  G. Pier.  Application of vaccine technology to prevention of Pseudomonas aeruginosa infections , 2005, Expert review of vaccines.

[137]  F. Gottrand,et al.  Long-Chain Polyunsaturated Fatty Acids Modulate Lung Inflammatory Response Induced by Pseudomonas aeruginosa in Mice , 2005, Pediatric Research.

[138]  M. Tosi.  Innate immune responses to infection. , 2005, The Journal of allergy and clinical immunology.

[139]  M. Kollef,et al.  Transfusion practice and blood stream infections in critically ill patients. , 2005, Chest.

[140]  J. Lorente,et al.  Survival Benefit in Critically Ill Burned Patients Receiving Selective Decontamination of the Digestive Tract: A Randomized, Placebo-Controlled, Double-Blind Trial , 2005, Annals of surgery.

[141]  T. Sawa,et al.  Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge. , 2005, Burns : journal of the International Society for Burn Injuries.

[142]  M. Smyth,et al.  Activation of NK cell cytotoxicity. , 2005, Molecular immunology.

[143]  D. Greenhalgh,et al.  DOWNREGULATION OF NF-κB ACTIVITY ASSOCIATED WITH ALTERATION IN PROLIFERATIVE RESPONSE IN THE SPLEEN AFTER BURN INJURY , 2005 .

[144]  E. Sherwood,et al.  Enhancement of Dendritic Cell Production by Fms-Like Tyrosine Kinase-3 Ligand Increases the Resistance of Mice to a Burn Wound Infection1 , 2005, The Journal of Immunology.

[145]  I. Altuntaş,et al.  Effects of granulocyte-colony stimulating factor on wound healing in a mouse model of burn trauma. , 2004, The Tohoku journal of experimental medicine.

[146]  A. Meyer,et al.  The effects of transforming growth factor-beta neutralization on postburn humoral immunity. , 2004, The Journal of trauma.

[147]  Soo-Yeon Lee,et al.  The limited immunomodulatory effects of escharectomy on the kinetics of endotoxin, cytokines, and adhesion molecules in major burns. , 2004, Mediators of inflammation.

[148]  M. Ansermino,et al.  Intensive care management and control of infection , 2004, BMJ : British Medical Journal.

[149]  D. White,et al.  Selective decontamination of the digestive tract attenuated the myocardial inflammation and dysfunction that occur with burn injury. , 2004, American journal of physiology. Heart and circulatory physiology.

[150]  R. Tompkins,et al.  Support of the metabolic response to burn injury , 2004, The Lancet.

[151]  D. Herndon,et al.  Insulin-like growth factor-I/insulin-like growth factor binding protein-3 alters lymphocyte responsiveness following severe burn. , 2004, The Journal of surgical research.

[152]  E. Ulvestad,et al.  Concentrations of cytokines in plasma of patients with large burns: their relation to time after injury, burn size, inflammatory variables, infection, and outcome. , 2003, The European journal of surgery = Acta chirurgica.

[153]  J. Bernier,et al.  Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: A prospective, controlled, randomized clinical trial* , 2003, Critical care medicine.

[154]  N. H. Steigbigel.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock , 2003, Current infectious disease reports.

[155]  P. Bossuyt,et al.  Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial , 2003, The Lancet.

[156]  G. Germann,et al.  Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients. , 2003, FEMS immunology and medical microbiology.

[157]  Tomas Ganz,et al.  The Role of Antimicrobial Peptides in Innate Immunity1 , 2003, Integrative and comparative biology.

[158]  M. Schwacha.  Macrophages and post-burn immune dysfunction. , 2003, Burns : journal of the International Society for Burn Injuries.

[159]  A. Yamauchi,et al.  IFN-γ Production from Liver Mononuclear Cells of Mice in Burn Injury As Well As in Postburn Bacterial Infection Models and the Therapeutic Effect of IL-18 , 2002, The Journal of Immunology.

[160]  A. Masamune,et al.  Human Leukocyte Antigen-DR Expression on Peripheral Monocytes as a Predictive Marker of Sepsis During Acute Pancreatitis , 2002, Pancreas.

[161]  I. Chaudry,et al.  The cellular basis of post-burn immunosuppression: macrophages and mediators. , 2002, International journal of molecular medicine.

[162]  G. Hempelmann,et al.  Alterations of acute phase reaction and cytokine production in patients following severe burn injury. , 2002, Burns : journal of the International Society for Burn Injuries.

[163]  E. Tredget,et al.  Alterations in lymphocyte function and relation to phospholipid composition after burn injury in humans , 2002, Critical care medicine.

[164]  M. Lyte,et al.  Increased IL-10 Production and HLA-DR Suppression in the Lungs of Injured Patients Precede the Development of Nosocomial Pneumonia , 2002, Shock.

[165]  R. Bellomo,et al.  A phase II randomized, controlled trial of continuous hemofiltration in sepsis , 2002, Critical care medicine.

[166]  J. Morgan,et al.  Interleukin-1&agr; and Interleukin-6 Enhance the Antibacterial Properties of Cultured Composite Keratinocyte Grafts , 2002, Annals of surgery.

[167]  R. Sheridan.  A great constitutional disturbance. , 2001, The New England journal of medicine.

[168]  D. Chinkes,et al.  Reversal of catabolism by beta-blockade after severe burns. , 2001, The New England journal of medicine.

[169]  A. Neely,et al.  PcrV Immunization Enhances Survival of Burned Pseudomonas aeruginosa-Infected Mice , 2001, Infection and Immunity.

[170]  R. Sheridan,et al.  Antibiotic prophylaxis for group A streptococcal burn wound infection is not necessary. , 2001, The Journal of trauma.

[171]  D. Herndon,et al.  Selective decontamination of the digestive tract in severely burned pediatric patients. , 2001, Burns : journal of the International Society for Burn Injuries.

[172]  M. A. de la Cal,et al.  Pneumonia in patients with severe burns : a classification according to the concept of the carrier state. , 2001, Chest.

[173]  F. Moore,et al.  Effects of immune-enhancing diets on infectious morbidity and multiple organ failure. , 2001, JPEN. Journal of parenteral and enteral nutrition.

[174]  G. Xiao,et al.  Effects of early enteral feeding on the prevention of enterogenic infection in severely burned patients. , 2001, Burns : journal of the International Society for Burn Injuries.

[175]  F. Moore,et al.  POST‐INJURY MULTIPLE ORGAN FAILURE: THE ROLE OF THE GUT , 2001, Shock.

[176]  J. J. Kim,et al.  Comparison of two immunization schedules for a Pseudomonas aeruginosa outer membrane proteins vaccine in burn patients. , 2000, Vaccine.

[177]  I. Chaudry,et al.  Does burn wound excision after thermal injury attenuate subsequent macrophage hyperactivity and immunosuppression? , 2000, Shock.

[178]  Robert Blumenthal,et al.  The Structure of Human β-Defensin-2 Shows Evidence of Higher Order Oligomerization* , 2000, The Journal of Biological Chemistry.

[179]  L. Moldawer,et al.  Glucocorticoid and Fas ligand induced mucosal lymphocyte apoptosis after burn injury. , 2000, The Journal of trauma.

[180]  M. Fisher,et al.  Predictors of infectious complications after burn injuries in children , 2000, The Pediatric infectious disease journal.

[181]  H. D. Shen,et al.  Changes in circulating levels of an anti-inflammatory cytokine interleukin 10 in burned patients. , 2000, Burns : journal of the International Society for Burn Injuries.

[182]  S. Romagnani,et al.  T-cell subsets (Th1 versus Th2). , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[183]  V. C. Pratt,et al.  Glutamine and arginine: immunonutrients for improved health. , 2000, Medicine and science in sports and exercise.

[184]  H. Lodish,et al.  Role of transforming growth factor beta in human disease. , 2000, The New England journal of medicine.

[185]  D. Orgill,et al.  The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury. , 2000, Journal of critical care.

[186]  J. J. Kim,et al.  Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy. , 2000, Vaccine.

[187]  J. Lederer,et al.  Injury induces deficient interleukin-12 production, but interleukin-12 therapy after injury restores resistance to infection. , 2000, Annals of surgery.

[188]  E. Kreuzfelder,et al.  Reduced B cell HLA-DR expression and natural killer cell counts in patients prone to sepsis after injury. , 1999, The European journal of surgery = Acta chirurgica.

[189]  F. D. Moore.  Then and now: treatment volume, wound coverage, lung injury, and antibiotics: a capsule history of burn treatment at mid-century. , 1999, Burns : journal of the International Society for Burn Injuries.

[190]  J. Olshaker,et al.  The C-reactive protein. , 1999, The Journal of emergency medicine.

[191]  J. Pittet,et al.  Interleukin-8 mediates injury from smoke inhalation to both the lung endothelial and the alveolar epithelial barriers in rabbits. , 1999, American journal of respiratory and critical care medicine.

[192]  D. Herndon,et al.  Therapeutic protective effects of IL-12 combined with soluble IL-4 receptor against established infections of herpes simplex virus type 1 in thermally injured mice. , 1999, Journal of immunology.

[193]  B. Bozkurt,et al.  An overview of tumor necrosis factor α and the failing human heart , 1999 .

[194]  A. Meyer,et al.  Transforming growth factor-beta impairs postburn immunoglobulin production by limiting B-cell proliferation, but not cellular synthesis. , 1999, The Journal of trauma.

[195]  M. Haller,et al.  Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. , 1999, Critical care medicine.

[196]  R. Barrow,et al.  Growth Hormone Attenuates Tumor Necrosis Factor α in Burned Children , 1999 .

[197]  N. Pallua,et al.  Association between Reduced Human Leukocyte Antigen (HLA)-DR Expression on Blood Monocytes and Increased Plasma Level of Interleukin-10 in Patients with Severe Burns , 1999, Clinical chemistry and laboratory medicine.

[198]  P. Bayer,et al.  Differential expression of tumor necrosis factor receptor subtypes on leukocytes in systemic inflammatory response syndrome. , 1999, Critical care medicine.

[199]  M. Schaller,et al.  Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group. , 1998, Critical care medicine.

[200]  Y. Chen,et al.  Plasma tumor necrosis factor-α, its soluble receptors and interleukin-1β levels in critically burned patients , 1998 .

[201]  S. Streat,et al.  Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis--a randomized, clinical trial. , 1998, Critical care medicine.

[202]  F. Spertini,et al.  Trace element supplementation modulates pulmonary infection rates after major burns: a double-blind, placebo-controlled trial. , 1998, The American journal of clinical nutrition.

[203]  C. Ryan,et al.  Death in the burn unit: sterile multiple organ failure. , 1998, Burns : journal of the International Society for Burn Injuries.

[204]  S. Nasraway,et al.  Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock , 1998, The Lancet.

[205]  G. Steinmann,et al.  Interferon-gamma in the prevention of severe burn-related infections: a European phase III multicenter trial. The Severe Burns Study Group. , 1998, Critical care medicine.

[206]  W. Silvester,et al.  Mediator removal with CRRT: complement and cytokines. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[207]  C. Janeway,et al.  Innate Immunity: The Virtues of a Nonclonal System of Recognition , 1997, Cell.

[208]  G. Wakabayashi,et al.  Anti-inflammatory cytokine levels in patients with septic shock. , 1997, Research communications in molecular pathology and pharmacology.

[209]  J. Meis,et al.  A primer on cytokines: sources, receptors, effects, and inducers , 1997, Clinical microbiology reviews.

[210]  J. Lederer,et al.  Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. , 1997, Annals of surgery.

[211]  T. Staudinger,et al.  Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. , 1997, American journal of respiratory and critical care medicine.

[212]  J. Peters,et al.  Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNFα plasma concentrations , 1997, Intensive Care Medicine.

[213]  S. Opal,et al.  Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. , 1997, Critical care medicine.

[214]  Yan Yu,et al.  Influence of selective decontamination of the digestive tract on cell-mediated immune function and bacteria/endotoxin translocation in thermally injured rats. , 1997, The Journal of trauma.

[215]  W. Knaus,et al.  Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and Sepsis Study Group. , 1997, JAMA.

[216]  W. L. Lin,et al.  Changes in serum tumour necrosis factor-α in burned patients , 1997 .

[217]  K. Inada,et al.  Plasma cytokine levels in patients with severe burn injury--with reference to the relationship between infection and prognosis. , 1996, Burns : journal of the International Society for Burn Injuries.

[218]  A. Meyer,et al.  Effect of cyclo-oxygenase inhibition on in vitro B-cell function after burn injury. , 1996, The Journal of trauma.

[219]  J. Carlet,et al.  INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. , 1996, Critical care medicine.

[220]  R. Bone,et al.  Sir Isaac Newton, sepsis, SIRS, and CARS. , 1996, Critical care medicine.

[221]  D. Herndon,et al.  Interleukin‐12 protects thermally injured mice from herpes simplex virus type 1 infection , 1996, Journal of leukocyte biology.

[222]  A. Bidani,et al.  Early effects of smoke inhalation on alveolar macrophage functions. , 1996, Burns : journal of the International Society for Burn Injuries.

[223]  G. Hill,et al.  Blood Transfusion-Induced Immunomodulation , 1996, Anesthesia and analgesia.

[224]  J. Meakins,et al.  Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. , 1995 .

[225]  D. Cook,et al.  Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. , 1995, Critical care medicine.

[226]  A. Meyer,et al.  Immunoglobulin M synthesis after burn injury: the effects of chronic ethanol on postinjury synthesis. , 1995, The Journal of burn care & rehabilitation.

[227]  R. F. Johnston,et al.  Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial , 1994 .

[228]  K. Collins,et al.  The humoral immune response after thermal injury: an experimental model. , 1994, Surgery.

[229]  L. Hinshaw,et al.  Preclinical review of anti‐tumor necrosis factor monoclonal antibodies , 1993, Critical care medicine.

[230]  A. Drost,et al.  Plasma cytokines following thermal injury and their relationship with patient mortality, burn size, and time postburn. , 1993, The Journal of trauma.

[231]  J. de Haro,et al.  Prognostic value of the CD4/CD8 lymphocyte ratio in moderately burned patients. , 1993, Burns : journal of the International Society for Burn Injuries.

[232]  J. Vincent,et al.  Influence of an anti‐tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis , 1993, Critical care medicine.

[233]  J. Hansbrough,et al.  Temporal analysis of human leucocyte surface antigen expression and neutrophil respiratory burst activity after thermal injury. , 1993, Burns : journal of the International Society for Burn Injuries.

[234]  R. Tompkins,et al.  Circulating interleukin‐1β and tumor necrosis factor‐α concentrations after burn injury in humans , 1992 .

[235]  P. Christiansen,et al.  Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery , 1992, The British journal of surgery.

[236]  D. Mackie,et al.  Prevention of infection in burns: preliminary experience with selective decontamination of the digestive tract in patients with extensive injuries. , 1992, The Journal of trauma.

[237]  G. Mills,et al.  Immunosuppression follows systemic T lymphocyte activation in the burn patient , 1991, Clinical and experimental immunology.

[238]  W. König,et al.  Differential regulation of T- and B-lymphocyte activation in severely burned patients. , 1991, The Journal of trauma.

[239]  J. Solomkin.  Neutrophil disorders in burn injury: complement, cytokines, and organ injury. , 1990, The Journal of trauma.

[240]  A. Luterman,et al.  In vitro effects of complement inactivation upon burn-associated cell-mediated immunosuppression. , 1990, The American surgeon.

[241]  J. Alexander,et al.  Nutritional immunomodulation in burn patients , 1990, Critical care medicine.

[242]  J. Hunt,et al.  A clinical trial of i.v. tetravalent hyperimmune Pseudomonas globulin G in burned patients. , 1988, Journal of Trauma.

[243]  M. Gadd,et al.  Immune response modulation after burn injury: T cells and antibodies. , 1987, The Journal of burn care & rehabilitation.

[244]  D. Fearon,et al.  Neutrophil activation after burn injury: contributions of the classic complement pathway and of endotoxin. , 1987, Surgery.

[245]  H. E. Gilleland,et al.  Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model. , 1987, The Journal of infectious diseases.

[246]  M. Fons,et al.  Defective NK cell activity following thermal injury. , 1986, Clinical and experimental immunology.

[247]  R. Falk,et al.  Polyclonal immunoglobulin production in burned patients--kinetics and correlations with T-cell activity. , 1986, The Journal of trauma.

[248]  T. Kupper,et al.  The human burn wound as a primary source of interleukin-1 activity. , 1986, Surgery.

[249]  Alexander Jw,et al.  The importance of lipid type in the diet after burn injury. , 1986 .

[250]  D. Herndon,et al.  Comparison of serial debridement and autografting and early massive excision with cadaver skin overlay in the treatment of large burns in children. , 1986, The Journal of trauma.

[251]  L. Old,et al.  Tumor necrosis factor (TNF). , 1985, Science.

[252]  D. Metcalf.  Granulocyte-macrophage colony-stimulating factors , 1985, Science.

[253]  K. Brackett,et al.  Mechanism of Prevention of Postburn Hypermetabolism and Catabolism by Early Enteral Feeding , 1984, Annals of surgery.

[254]  D. Herndon,et al.  Natural killer cell defects resulting from thermal injury. , 1984, Cellular immunology.

[255]  J. Gelfand,et al.  Preferential Activation and Depletion of the Alternative Complement Pathway by Burn Injury , 1983, Annals of surgery.

[256]  R. J. Jones,et al.  Active and passive immunization against Pseudomonas aeruginosa infection of burned patients. , 1983, Burns, including thermal injury.

[257]  J. Gelfand,et al.  Alternative complement pathway activation increases mortality in a model of burn injury in mice. , 1982, The Journal of clinical investigation.

[258]  S H Rosenbaum,et al.  Respiratory changes induced by the large glucose loads of total parenteral nutrition. , 1980, JAMA.

[259]  R. J. Jones,et al.  CONTROLLED TRIALS OF A POLYVALENT PSEUDOMONAS VACCINE IN BURNS , 1979, The Lancet.

[260]  R. Wolfe,et al.  Glucose metabolism in severely burned patients. , 1979, Metabolism: clinical and experimental.

[261]  J. Moylan,et al.  Clinical experience with prophylactic antibiotic bowel suppression in burn patients. , 1978, Surgery.

[262]  A. Mason,et al.  Effect of carbohydrate and fat intake on nitrogen excretion during total intravenous feeding. , 1977, Annals of surgery.

[263]  Z. Janžekovič,et al.  A new concept in the early excision and immediate grafting of burns. , 1970, The Journal of trauma.

[264]  F. Foley,et al.  Disseminated cytomegalic inclusion disease in a burned adult. , 1970, JAMA.

[265]  D. Culnan,et al.  Hematology, Hemostasis, Thromboprophylaxis, and Transfusion Medicine in Burn Patients , 2018 .

[266]  N. Gibran,et al.  Evaluation of the Burn Wound: Management Decisions , 2018 .

[267]  D. Annane,et al.  Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. , 2018, Critical care medicine.

[268]  Jui-yung Yang,et al.  A Comparison of Gene Expression of Decorin and MMP13 in Hypertrophic Scars Treated With Calcium Channel Blocker, Steroid, and Interferon: A Human-Scar-Carrying Animal Model Study , 2017, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[269]  G. Van den Berghe,et al.  Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. , 2017, Critical care medicine.

[270]  R. Cox,et al.  Dendritic cells modulate burn wound healing by enhancing early proliferation , 2016, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[271]  T. Janssen,et al.  Effect of long-term physical activity and acute exercise on markers of systemic inflammation in persons with chronic spinal cord injury: a systematic review. , 2015, Archives of physical medicine and rehabilitation.

[272]  A. Buchovsky,et al.  Assessment of C-reactive protein and procalcitonin levels to predict infection and mortality in burn children. , 2015, Archivos argentinos de pediatria.

[273]  L. Ferreira,et al.  Keratinocyte growth factor, interleukins (1 beta, 6, 8, 10, 12), and tumor necrosis factor alpha in culture medium of dermal fibroblast of burned patients. , 2014, Acta cirurgica brasileira.

[274]  A. Desmoulière,et al.  Erythropoietin, a novel repurposed drug: An innovative treatment for wound healing in patients with diabetes mellitus , 2014, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[275]  V. Vieira-Potter,et al.  Adipose tissue inflammation and metabolic dysfunction: role of exercise. , 2014, Missouri medicine.

[276]  L. Ferreira,et al.  Innate and adaptive immunity gene expression of human keratinocytes cultured of severe burn injury. , 2014, Acta cirurgica brasileira.

[277]  A. Moris,et al.  The role of C-type lectin receptors in human skin immunity: immunological interactions between dendritic cells, Langerhans cells and keratinocytes , 2013 .

[278]  A. Grobbelaar,et al.  The role of the TGF-β family in wound healing, burns and scarring: a review. , 2012, International journal of burns and trauma.

[279]  C. Hivroz,et al.  Crosstalk between T lymphocytes and dendritic cells. , 2012, Critical reviews in immunology.

[280]  H. Hirasawa,et al.  Treatment of severe sepsis and septic shock by CHDF using a PMMA membrane hemofilter as a cytokine modulator. , 2010, Contributions to nephrology.

[281]  Yan Yu,et al.  Association between regulatory T cell activity and sepsis and outcome of severely burned patients: a prospective, observational study , 2010 .

[282]  G. J. Crystal,et al.  Persistency and pathway of isoflurane-induced inhibition of superoxide production by neutrophils , 2010, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[283]  F. Gottrand,et al.  Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro- and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection. , 2009, The Journal of nutrition.

[284]  A. Namazov,et al.  Disorders of the immune system in severely burned patients. , 2009, Annals of burns and fire disasters.

[285]  Effie W Petersdorf,et al.  Nomenclature for Factors of the HLA System, 2004. , 2005, Human immunology.

[286]  Redmond Hp,et al.  Effects of Volatile and Intravenous Anesthetic Agents on Neutrophil Function , 2003, International anesthesiology clinics.

[287]  R. Gibson,et al.  Dietary polyunsaturated fatty acids and inflammatory mediator production. , 2000, The American journal of clinical nutrition.

[288]  M. Yoshida,et al.  Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns. , 1996, Journal of medicine.

[289]  J. Nerup,et al.  Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury. , 1995, Critical care medicine.

[290]  M. Falchi,et al.  Influence of inhalational, neuroleptic and local anaesthesia on lymphocyte subset distribution. , 1995, International journal of tissue reactions.

[291]  L. Saravolatz,et al.  The role of tumor necrosis factor in sepsis. , 1992, Clinical immunology and immunopathology.

[292]  L. Marnett,et al.  Prostaglandin and thromboxane biosynthesis. , 1991, Pharmacology & therapeutics.

[293]  B. Jordan,et al.  Effects of granulocyte-macrophage colony-stimulating factor in burn patients. , 1991, Archives of surgery.

[294]  P. Barie,et al.  Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. , 1990, Surgery, gynecology & obstetrics.

[295]  C. Janeway.  Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.

[296]  B. Beutler,et al.  The biology of cachectin/TNF--a primary mediator of the host response. , 1989, Annual review of immunology.

[297]  R. Winchurch,et al.  Depressed natural killer cell function in thermally injured adults: successful in vivo and in vitro immunomodulation and the role of endotoxin. , 1988, Clinical and experimental immunology.

[298]  L. Landsberg,et al.  Insulin-mediated glucose metabolism in the relationship between dietary intake and sympathetic nervous system activity. , 1985, International journal of obesity.

[299]  Cora K. Ogle,et al.  Beneficial effects of aggressive protein feeding in severely burned children. , 1980 .

[300]  V. Banssillon,et al.  [Anesthesia of burned patients]. , 1977, Annales de l'anesthesiologie francaise.